---
title: "WOOSLEY RAYMOND L. — Ownership Dossier"
canonical: https://whiteintel.dev/entity/ac779b82-4c33-5950-b248-76f0a770ca58
json: https://whiteintel.dev/api/public/dossier/ac779b82-4c33-5950-b248-76f0a770ca58
identifier: sec:0001582095
jurisdiction: US
risk: Low
source: WhiteIntel corporate-ownership graph
---

# WOOSLEY RAYMOND L.

**Type:** Company  
**Jurisdiction:** US  
**Identifier:** `sec:0001582095`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/ac779b82-4c33-5950-b248-76f0a770ca58  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/ac779b82-4c33-5950-b248-76f0a770ca58  

## Ownership & control

### Holdings / subsidiaries

- **Oruka Therapeutics, Inc.** (director) — https://whiteintel.dev/entity/7e85ba7b-eb29-5fad-98be-13d2eb920dce

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **WOOSLEY RAYMOND L.**. Human view: https://whiteintel.dev/entity/ac779b82-4c33-5950-b248-76f0a770ca58 · Structured JSON: https://whiteintel.dev/api/public/dossier/ac779b82-4c33-5950-b248-76f0a770ca58._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._